PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 677 of 767

Advanced search
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

UKHSA update on the hantavirus cruise ship outbreak

Latest information on cases including British nationals.

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Innovo Therapeutics scores Korean phase 3 approval for scar treatment, INV-001

koreabiomed.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Regulatory round-up: 22 June 2026

The Pharma LetterOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Weekly all-cause mortality surveillance: week ending 21 June 2026

How the actual number of deaths in England compare with expected numbers for each week.

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ildong Pharmaceutical Group to attend BIO USA, advance global partnering for GLP-1 obesity drug candidates

더바이오Original source
🌍discoverynews.google.comTier 3 · Aggregated media

MoonLake’s Sonelokimab Achieves 67% HiSCR75 Response in Phase 3 HS Trial

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA approves Moderna's new mRNA-based flu vaccine

The Jerusalem PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Innovent doses first patient in multiple myeloma trial

Vietnam Investment Review - VIROriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Recce Pharmaceuticals Advances Diabetic Foot Infection Trial to Pivotal Phase 3

smallcaps.com.auOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA cites four importers for verification failures involving produce, dairy ingredients

Food Safety NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmacogenomics Genetics Drugs Clinical Interplay

Pharmacy Practice NewsOriginal source
🇺🇸Regulatoryfda.govTier 1 · Regulatory source

Infant Resuscitation System Correction: GE HealthCare Issues Correction for Giraffe and Panda Infant Resuscitation Systems and Warmers with a M1091607-R Blender

The air-oxygen blender knob shaft on certain integrated and stand-alone Resuscitation systems can lo...

FDA MedWatchOriginal source
🇺🇸Regulatoryfda.govTier 1 · Regulatory source

Heart Pump Controller Correction: Abiomed Updates Use Instructions for Automated Impella Controllers

A software error may cause the Automated Impella Controller to restart when used in conjunction with...

FDA MedWatchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

MoonLake Immunotherapeutics (MLTX) Reports Positive Phase 3 Clin

GuruFocusOriginal source
🌍Researchpnas.orgTier 2 · Direct publisher

Horizontal gene transfer observed in human cells

PNASOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Announces Recall of Great Value Hawaiian Rolls Over Packaging Contamination

HarianBasis.coOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

PRG S&Tech Receives Therapeutic Use Approval for NF2 Treatment 'Trineumin'

아시아경제Original source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

AbbVie filed Form 8-K

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

GSK filed Form 6-K

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Sanofi filed Form 6-K

SEC EDGAROriginal source
🇺🇰Regulatorynice.org.ukTier 1 · Regulatory source

From £1 to £180: how NICE guidance helped us make smarter slide sheet choices

NICEOriginal source
🇿🇦Researchnews.uct.ac.zaTier 2 · Direct publisher

UCT study finds toxic pollutants in False Bay waters

University of Cape TownOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Medical Devices; Gastroenterology-Urology Devices; Classification of the Endoscopic Traction Device

The Food and Drug Administration (FDA) is classifying the endoscopic traction device into class II (...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Medical Devices; Gastroenterology-Urology Devices; Classification of the Endoscopic Light-Projecting Measuring Device

The Food and Drug Administration (FDA) is classifying the endoscopic light-projecting measuring devi...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Medical Devices; Immunology and Microbiology Devices; Classification of the Simple In Vitro Diagnostic Device for the Detection of Secreted Proteins From Bacillus Species (spp.) in Human Clinical Samples

The Food and Drug Administration (FDA) is classifying the simple in vitro diagnostic device for the...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

340B Rebate Model Pilot Program Application, Implementation, and Evaluation, Correction

HRSA published a 30-day Federal Register Notice (FRN) on June 15, 2026, related to the proposed Info...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Epizyme, Inc.; Withdrawal of Approval of New Drug Application for TAZVERIK (Tazemetostat) Tablet, 200 Milligrams

The Food and Drug Administration (FDA or Agency) is withdrawing approval of new drug application (ND...

Federal RegisterOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: 4% Lidocaine Pain Relief Patch

Official structured record identifier: 4981e9c3-2a19-aed8-e063-6294a90af216.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Medline

Official structured record identifier: 495076e9-3187-6bfa-e063-6394a90a01f5.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Doxepin hydrochloride

Official structured record identifier: 46be666a-fb9f-42a5-a55c-ea15fd5538c9.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Vicks DayQuil and Vicks NyQuil Severe Cold and Flu

Official structured record identifier: 4147ff00-8e21-7335-e054-00144ff88e88.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: meloxicam

Official structured record identifier: 3e8a6283-1e1b-4199-ac73-f42255c7e907.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Naproxen Sodium

Official structured record identifier: 3d01220c-c5ec-4604-8cef-9ecb807ccd53.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Ipratropium Bromide and Albuterol Sulfate

Official structured record identifier: 3c64255e-074c-41f8-a344-3686a0685020.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Allergy Relief

Official structured record identifier: 3c1953a1-32e9-6c81-e063-6294a90a9fa2.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Tolnaftate

Official structured record identifier: 365f6f60-e056-51bd-e063-6294a90ad01e.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: tacrolimus

Official structured record identifier: 3519febc-c9df-4559-b07a-92f8b0c7e770.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Vicks DayQuil and Vicks NyQuil INTENSE FLU

Official structured record identifier: 32bea3dc-9889-22dd-e063-6394a90afa1b.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Vicks DayQuil INTENSE FLU

Official structured record identifier: 326ed27d-cbfa-5513-e063-6394a90a41bf.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Benzethonium chloride and Dyclonine hydrochloride

Official structured record identifier: 326daa64-165a-cea6-e063-6294a90afbab.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Vicks NyQuil ALLERGY

Official structured record identifier: 2f9b3bbb-4494-065d-e063-6294a90afcd2.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Vicks NyQuil Kids ALLERGY

Official structured record identifier: 2f9a6d65-f849-af0a-e063-6394a90ae435.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Vicks DayQuil Kids and Vicks NyQuil Kids COLD and COUGH plus FEVER

Official structured record identifier: 2d430264-074d-fb22-e063-6294a90a57f6.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: ATORVASTATIN CALCIUM

Official structured record identifier: 1ea6235f-633c-af0b-e063-6294a90aad6d.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Vicks DayQuil Severe Honey Cold and Flu

Official structured record identifier: 1b579102-9eac-1b2f-e063-6394a90add0a.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Nighttime Sleep Aid

Official structured record identifier: 1b40e794-089f-4546-8f8d-ba7016cd4e7f.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Glipizide

Official structured record identifier: 1b2ef6e2-5e7c-761e-e063-6294a90addd0.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Vicks NyQuil Kids COLD and COUGH plus FEVER

Official structured record identifier: 1a01d4f7-37ed-bb92-e063-6294a90a208c.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Vicks DayQuil Kids COLD and COUGH plus FEVER

Official structured record identifier: 1a01b294-a5ee-ab35-e063-6394a90a4a1a.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: PredniSONE

Official structured record identifier: 16ee689e-c7a9-3a5a-e063-6394a90a6ea2.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: unspecified product

Official structured record identifier: 0e8a069b-bcdd-4301-ab8b-17cf70ca050f.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Triamcinolone Acetonide

Official structured record identifier: 089a8449-7810-48ec-b327-494f058c3348.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Letrozole

Official structured record identifier: 065cc89f-3a3f-4d78-b9f6-1c32a77ceb1c.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Vicks DayQuil and Vicks NyQuil Cold and Flu

Official structured record identifier: 04dc3835-64be-d9e4-e063-6394a90a8599.

openFDA Drug LabelsOriginal source
🌍discoverynews.google.comTier 1 · Regulatory source

Accelerating and Modernizing Early and Late-Stage Clinical Development

fda.govOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Joint Clinical Assessment in the EU HTA Regulation-Would Drugs Supported by Single-Arm Trials Fit Under Evaluation?

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Lamotrigine serum concentrations as longitudinal biomarkers for seizure risk prediction in pregnant women with epilepsy: a secondary analysis of the EMPiRE study.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin Structure Infections.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Characterizing the MRI signature of hippocampal sclerosis of aging.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Collaborative care intervention for risky opioid use among primary care patients: The STOP randomized clinical trial.

Europe PMCOriginal source